SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The Board declared on September 18, 2026 an increase in the quarterly cash dividend from $0.25 to $0.2625 per share (a 5% increase), payable November 6, 2026 to shareholders of record on October 9, 2026, reflecting the company's strong operating performance and financial position.
View raw filing on EDGAR →Galaxy Gaming entered into an Amended and Restated Employment Agreement with CEO Matt Reback establishing compensatory arrangements including base salary of $367,500–$385,000, annual discretionary bonus of 75% of base salary, a stock option grant of 150,000 shares at $1.656, and a conditional restricted stock grant of 150,000 shares through May 31, 2029.
View raw filing on EDGAR →The filing discloses BancFirst Corporation's Board declaration of a $0.52 per share cash dividend on common stock payable October 15, 2026, along with a quarterly interest payment on junior subordinated debentures that will fund a $0.45 per share dividend on trust preferred securities. This is a routine but material dividend declaration affecting both common and preferred shareholders.
View raw filing on EDGAR →The filing discloses an ongoing private placement offering of up to $2.165 billion of common shares across multiple classes, with $546.749 million raised as of August 31, 2026. This represents a material dilutive issuance of equity securities. While the disclosure also mentions dividend declarations and DRIP activity, the primary focus of the Item 8.01 section is the status and scale of the continuous private offering, which is a classic dilutive equity issuance event material to investors assessing ownership dilution and capital structure.
View raw filing on EDGAR →Sangamo Therapeutics filed for Chapter 11 bankruptcy protection, as disclosed under Item 1.03.
View raw filing on EDGAR →Sangamo completed the sale of substantially all assets to PTC Therapeutics for $111 million in cash plus up to $100 million in contingent consideration pursuant to a court-approved Asset Purchase Agreement dated August 25, 2026.
View raw filing on EDGAR →Electra Therapeutics completed its initial public offering on September 21, 2026, issuing 23,333,334 shares at $15.00 per share and generating approximately $350.0 million in gross proceeds.
View raw filing on EDGAR →CDW completed the sale of $1.5 billion in aggregate principal amount of senior notes across three tranches (2029, 2032, and 2033 maturities) on September 21, 2026, pursuant to supplemental indentures. This material debt issuance creates direct financial obligations and significantly affects the company's capital structure and leverage.
View raw filing on EDGAR →The disclosure describes a material acquisition in progress: Lantheus entered into a Merger Agreement with Curium US Holdings LLC on August 3, 2026, whereby Merger Sub will merge with Lantheus. The Item 8.01 filing updates the status of HSR antitrust review, noting that Parent voluntarily withdrew and resubmitted its HSR notification on September 17 and September 21, 2026, respectively, commencing a new 30-day waiting period expiring October 21, 2026. The parties expect to consummate the Merger in the first half of 2027, subject to regulatory approvals and stockholder adoption. This is a material acquisition event requiring disclosure of regulatory progress.
View raw filing on EDGAR →Sixth Street Lending Partners issued $750 million in aggregate principal amount of 6.500% notes due 2031 pursuant to a Fifth Supplemental Indenture dated September 21, 2026. The transaction closed on the filing date, with net proceeds intended for repayment of existing indebtedness and general corporate purposes.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from the Company's 2026 Annual Meeting of Stockholders held on September 16, 2026. The filing reports voting outcomes for two proposals: (i) election of five directors to the Board, with detailed vote tallies for each nominee (votes for, against, abstained, and broker non-votes), and (ii) ratification of KPMG LLP as independent auditor. This is the quintessential Item 5.07 disclosure and matches the shareholder_vote_results event type precisely.
View raw filing on EDGAR →Brown-Forman completed the issuance of $500 million in 5.375% Notes due 2031 pursuant to an underwriting agreement dated September 17, 2026, representing a material creation of a direct financial obligation that affects the company's capital structure.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Scholastic's annual meeting held on September 16, 2026. The filing reports final vote tallies on director nominees (for both Class A and Common stockholders) and approval of fiscal 2026 named executive officer compensation. Item 5.07 is the designated 8-K item for shareholder vote results, and the prose directly presents voting outcomes with vote counts for each matter submitted to security holders.
View raw filing on EDGAR →AnaptysBio issued a press release on September 21, 2026, announcing financial results for the three months and transitional fiscal year ended June 30, 2026. The disclosure includes consolidated balance sheets, statements of operations, and comprehensive loss data, along with key financial metrics such as collaboration revenue of $27.5 million and $53.0 million for the three and six months ended June 30, 2026, and net income from continuing operations of $177.3 million and $176.4 million respectively. This is a standard earnings release disclosure under Item 2.02, material to investors assessing the registrant's financial performance and royalty-generating capacity from its Jemperli and Quimilza collaborations.
View raw filing on EDGAR →The disclosure announces the European Commission's grant of marketing authorization for two obicetrapib formulations (Ubeslo® and Evlarco®), representing the first worldwide regulatory approval of this drug candidate. This is a material operational and commercial milestone for a pharmaceutical company, triggering milestone payments in the "mid-teens of millions of euros" and establishing the foundation for commercialization in Europe through the Menarini partnership. While not a traditional M&A transaction or earnings release, this regulatory approval is a transformative operational event that would materially affect investor assessment of the company's pipeline and revenue prospects.
View raw filing on EDGAR →PennantPark Private Income Fund completed an unregistered sale of 32,047 common shares for approximately $830,000 to accredited investors pursuant to Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →Jaguar Health completed a 1-for-15 reverse stock split effective September 17, 2026, reducing outstanding shares from approximately 7.8 million to 520,088. The reverse split modified security holder rights and the company's capital structure, with details disclosed across Items 3.03 and 8.01.
View raw filing on EDGAR →Millrose Properties entered into a Commitment and Acceptance on September 21, 2026, that increases the aggregate commitments under its Revolving Credit Facility by $50 million to $1.385 billion through exercise of an accordion feature, materially expanding the company's credit capacity and direct financial obligations.
View raw filing on EDGAR →Jason Williams, Executive Vice President and Chief Administrative Officer and principal accounting officer, notified the Company on September 18, 2026 of his intent to retire in July 2027. Although he will remain in his current role until a successor is identified and transition to an advisory role post-retirement, the principal disclosed action is his departure from the Company. The departure of a principal accounting officer is material to investors' assessment of financial reporting controls and governance continuity.
View raw filing on EDGAR →Jason Williams, Executive Vice President and Chief Administrative Officer and principal accounting officer, notified the Company on September 18, 2026 of his intent to retire in July 2027. Although he will remain in his current role until a successor is identified and transition to an advisory role post-retirement, the principal disclosed action is his departure from the Company. The departure of a principal accounting officer is material to investors assessing financial reporting oversight and internal controls.
View raw filing on EDGAR →Insulet entered into the Ninth Amendment to its Credit Agreement on September 21, 2026, refinancing $475 million in existing term loans at improved interest rates (0.25% lower margin) and increasing revolving credit commitments by $250 million to $750 million total.
View raw filing on EDGAR →Generation Income Properties entered into a warrant inducement agreement whereby an investor exercised existing warrants for approximately $4.3 million in gross proceeds and received unregistered "Reload Warrants" to purchase 8,148,718 additional shares at $1.05 per share (representing 200% of the exercised warrants). This private placement of unregistered securities under Section 4(a)(2) materially increases shareholder dilution and is contingent on stockholder approval.
View raw filing on EDGAR →The exhibit announces the appointment of Conor McShane as Interim Chief Financial Officer, effective immediately. While the appointment itself is the primary disclosed action, the context reveals that the CFO appointment follows the Board's decision to place the incumbent CFO, Mark Thurston, on administrative leave pending an investigation into accounting treatment concerns. The appointment is material because it signals executive leadership change and underlying accounting concerns that could affect investor assessment of the company's financial integrity and governance.
View raw filing on EDGAR →STORE Capital completed the issuance of $542 million in aggregate principal amount of Master Funding Net-Lease Mortgage Notes, Series 2026-2, with $525 million sold to qualified institutional investors and $17 million retained by an affiliate. The company used net proceeds to redeem approximately $280 million of previously issued notes maturing in Q4 2026 and to fund growth.
View raw filing on EDGAR →Generation Income Properties completed multiple material real estate transactions during the second and third quarters of 2026: reacquisition of a 7-Eleven property in Washington, D.C. for $600,000 (June 16, 2026); disposition of a GSA-occupied Vacaville property for $2,475,000 (July 15, 2026); disposition of a Fresenius medical property in Chicago for $2,800,000 (August 21, 2026); and disposition of a six-property Dollar General portfolio for $6,246,221 aggregate purchase price (August 21, 2026). These transactions materially altered the Company's real estate portfolio composition and financial position.
View raw filing on EDGAR →This Item 7.01 disclosure furnishes a corporate presentation detailing Metagenomi's gene editing platform, lead program MGX-001 for hemophilia A, preclinical data, development roadmap, and pipeline expansion strategy. The presentation covers material operational and strategic information—including cash runway through Q4 2027, FDA pre-IND meeting completion in December 2025, planned Q4 2026 IND submission, and first-patient-dosed timeline in 2027—that would affect a reasonable investor's assessment of the company's clinical progress and capital adequacy. While the disclosure is operational and strategic rather than a specific event type (not M&A, not a restatement, not an impairment), it constitutes material disclosure of the company's therapeutic development status and near-term milestones.
View raw filing on EDGAR →John D. Walker's retirement as President, Garden Consumer Products, effective September 26, 2026, is a clear executive departure. The disclosure centers on a named officer leaving his position, which is material to investors assessing the company's leadership continuity and operational structure.
View raw filing on EDGAR →This press release announces completion of the dewatering programme at Redwing Mine, the first milestone in a five-step restart pathway for the asset. The disclosure is operational in nature—it reports progress on a material capital project and mine restart initiative that directly affects the company's production capacity and strategic objectives. While not fitting a discrete event category like M&A or workforce reduction, the achievement of a major operational milestone ahead of schedule on a key asset restart is material to investors assessing the company's execution capability and path to production.
View raw filing on EDGAR →This press release announces completion of the last patient visit in the Phase 2a INFORM-MS clinical trial of intranasal foralumab for Secondary Progressive Multiple Sclerosis. The company expects to lock the database and announce topline data in October. This is a material clinical development milestone for a clinical-stage biotech company's lead candidate, affecting investor assessment of pipeline progress and near-term catalysts, but it is not a discrete event type (earnings, M&A, executive change, etc.) — it is an operational/clinical milestone best classified as operational_other.
View raw filing on EDGAR →The press release announces that Scinai has regained compliance with Nasdaq's $1.00 minimum bid price requirement (Listing Rule 5550(a)(2)) after previously failing to maintain that threshold on March 12, 2026. The company's ADSs had fallen below $1.00 for 30 consecutive business days, triggering a delisting risk notice. This disclosure directly addresses a continued listing rule violation and its resolution, which is material to investors assessing the registrant's ability to remain listed on Nasdaq.
View raw filing on EDGAR →New Era's subsidiary TCDC PowerCo LLC entered into a 20-year Power Purchase Agreement with Luminant ET Services Company LLC on September 18, 2026, securing 200-207 MW of power for its Texas Critical Data Center project, along with a companion Development Framework Agreement granting Vistra a 5% equity interest and rights of first refusal/offer on future expansion. The agreement includes substantial credit support obligations ($116M letter of credit plus up to $82.8M additional security) and represents a foundational operational and financial commitment that materially reduces Phase 1 development risk.
View raw filing on EDGAR →Priority Technology Holdings entered into a definitive Agreement and Plan of Merger on September 18, 2026, whereby an investor group led by Chairman and CEO Thomas Priore will acquire all outstanding shares not already owned for $8.05 per share in cash, representing an enterprise value of approximately $1.6 billion. The transaction constitutes a material change of control that will take the company private, subject to customary closing conditions and stockholder approval, and was unanimously recommended by a special committee of independent and disinterested directors.
View raw filing on EDGAR →The disclosure describes receipt of a statement of work (SOW) under a previously-disclosed Master Services Agreement with a national retailer, committing the Client to purchase and deploy 200 DUST-E autonomous cleaning robots over five years with ancillary services. This is a material operational/commercial milestone—a significant product order from a major customer—but does not fit the specific categories of M&A, debt, equity issuance, or other named event types. It is clearly operational in nature and material to a reasonable investor assessing the company's revenue prospects and customer base.
View raw filing on EDGAR →The 6-K discloses the resignation of FundCertify CPA Professional Corporation as the Company's independent registered auditor effective September 16, 2026, and the simultaneous appointment of Privatco CPA Limited as the new auditor. Although the prior auditor's reports were unqualified and there were no disagreements on accounting principles, the filing does disclose a material weakness in internal controls over financial reporting (insufficient U.S. GAAP expertise, lack of internal audit function, and IT deficiencies), which is a reportable event under Item 16F of Form 20-F. This is a material auditor change requiring disclosure under Item 4.01 of Form 8-K (or its 6-K equivalent).
View raw filing on EDGAR →This Item 7.01 disclosure centers on a material acquisition—the proposed business combination between Inflection Point Acquisition Corp. VII and Elroy Air, Inc., announced June 26, 2026, with Merger Sub merging into Elroy Air and Inflection Point changing its name to "Elroy Air, Inc." post-closing. The filing furnishes an investor presentation prepared for an analyst day held September 21, 2026, in connection with the Business Combination. Although technically a Regulation FD disclosure, the substance is disclosure of an ongoing material M&A transaction with shareholder vote pending, making ma_activity the appropriate classification.
View raw filing on EDGAR →Evolution Metals & Technologies Corp. announced its inclusion in the Russell 3000® and Russell 2000® indexes effective September 21, 2026, following FTSE Russell's third-quarter IPO additions process. The filing emphasizes that approximately $12.2 trillion in assets are benchmarked to these indexes, positioning the company for increased institutional visibility and liquidity. While index inclusion is primarily a capital-markets recognition event rather than an operational or financial transaction, it is material to investors as it affects market accessibility and shareholder base composition. This does not fit neatly into earnings, M&A, debt, or other specific categories, making operational_other the most appropriate classification.
View raw filing on EDGAR →Faraday Future announced the launch of nine new EAI (Embodied AI) robot device configurations and four industry productivity solutions at its 919 event on September 19, 2026. The disclosure details new product lines (FF All-New Futurist, FF Master Mini, FX Aegis series) with specific pricing and technical specifications, along with a new "6+1" direct sales and robot-sharing rental network. This is a material operational and strategic business event—a significant product launch and go-to-market initiative—that does not fit the specific categories of earnings release, M&A, or other named event types. The materiality is supported by the company's emphasis on completing its "EAI Robot World 2.0" ecosystem and establishing new sales channels, which are core to its business strategy.
View raw filing on EDGAR →The 6-K discloses the appointment of Ms. Bekazela Matshazi as Co-Chief Executive Officer of Golden Sun Technology Group Limited, effective September 21, 2026. This is a material executive appointment to a C-suite position that would affect a reasonable investor's assessment of the company's leadership and governance. The disclosure includes her background and qualifications, consistent with standard executive appointment disclosures.
View raw filing on EDGAR →The Company issued Pre-Paid Purchase #3 ("PPP #3"), an unsecured debt instrument with a principal amount of $2,160,000 (including $160,000 original issue discount) and a purchase price of $2,000,000, accruing interest at 8% per annum. The instrument includes conversion features (mandatory share issuance upon missed amortization payments) and trigger events that can accelerate the balance and increase the interest rate to 18% per annum, making this a material debt issuance with embedded equity features. The Side Letter also restricts the Company's ability to make earnout payments to Vast Space, creating additional financial constraints tied to this financing.
View raw filing on EDGAR →The report discloses two executive changes: the resignation of Mr. Jun Jiang from director, CFO, and COO positions effective September 21, 2026, and the appointment of Ms. Fangfang Zhou as CFO effective the same date. While both a departure and appointment occur, the primary disclosed action is the appointment of Ms. Zhou to fill the CFO vacancy, making exec_appointment the best fit. The CFO role is material to investor assessment of financial reporting and governance.
View raw filing on EDGAR →The disclosure describes special one-time performance-based awards of Class B shares granted by the board and compensation committee to two executives: Mr. Lee Seng Chi (CEO and Chairman) valued at RM30 million (~US$7.4 million) and Mr. Thien Chiet Chai (director) valued at RM22.5 million (~US$5.6 million). These are compensatory arrangements for named executives with vesting conditions tied to future contract value, directly falling under exec_compensation. The aggregate value of approximately US$13 million and the involvement of the CEO and board make this material to a reasonable investor.
View raw filing on EDGAR →Tokyo Lifestyle Co., Ltd. announced a third-party allotment of 13,503,648 common shares (1,396,755 shares for cash + 12,106,893 shares via debt-to-equity swap) totaling approximately JPY 568.8 million. The debt-to-equity swap component converts JPY 510 million in subordinated loan receivables held by TOKUSHIN G.K. into equity, which is a classic dilutive issuance structure. This materially increases share count and dilutes existing shareholders.
View raw filing on EDGAR →The 6-K discloses results of an extraordinary general meeting of shareholders held on September 18, 2026, with voting outcomes on four proposals: (1) Share Consolidation (209,228,486 for, 61,676 against, 273 abstain); (2) Share Capital Reduction and Reorganization (209,228,566 for, 61,790 against, 79 abstain); (3) Amended and Restated Memorandum and Articles of Association (209,228,675 for, 61,677 against, 83 abstain); and (4) Adjournment (not presented due to sufficient votes on prior proposals). These are material capital structure changes requiring shareholder approval and would significantly affect investor holdings and rights.
View raw filing on EDGAR →The filing discloses entry into a material definitive agreement (Item 1.01) for the purchase of 32 GPU server units from Compal Electronics for approximately $18.8 million. While this is a capital equipment purchase agreement, it does not fit neatly into the standard financial categories (debt_issuance, ma_activity, etc.). The transaction represents a significant operational and strategic commitment to develop the Company's artificial intelligence computing infrastructure business, making it an operational event rather than a financial obligation or M&A activity.
View raw filing on EDGAR →The Company issued two unsecured promissory notes totaling $600,000 in principal to Daniel Fetters and Edward King on September 18, 2026. Although the notes bear no interest and are convertible into equity units at the Payees' option, the primary disclosed transaction is the creation of a direct financial obligation with defined maturity, repayment terms, and default provisions.
View raw filing on EDGAR →The Company issued unregistered equity units convertible from the promissory notes issued to Daniel Fetters and Edward King, representing a dilutive equity issuance as part of the financing transaction.
View raw filing on EDGAR →The Company amended its Sales Agreement to substitute StoneX Financial Inc. as the sales agent in place of Benchmark, reflecting a material change in the Company's equity distribution arrangement and capital markets counterparty.
View raw filing on EDGAR →The filing discloses a delisting notice from Nasdaq regarding failure to maintain the minimum bid price requirement ($1.00 per share for 30 consecutive business days), followed by subsequent regaining of compliance. Although the Company ultimately regained compliance, the initial delisting notice and the regulatory process constitute a material delisting-risk event that would affect investor assessment of the registrant's listing status and financial condition.
View raw filing on EDGAR →The filing discloses both the resignation of director Xiaoou Li and the appointment of Chao Liu as a new independent director on September 21, 2026. While both events occur, the substantive disclosure centers on Ms. Liu's appointment, including her background, qualifications, committee assignments, and independence determinations under Nasdaq rules. The resignation is presented as context for the vacancy being filled. Board composition changes affecting independence and committee membership are material to investors.
View raw filing on EDGAR →This exhibit is a Public Reprimand Letter from NYSE Regulation to SOS Limited for violations of the Exchange's disclosure policies (Sections 202.05 and 202.06 of the Listed Company Manual). The Company failed to timely disclose a material securities purchase agreement for 19 million shares and subsequently filed a false and misleading Form 6-K. While the underlying transaction (dilutive equity issuance) is material, the primary disclosure here is the regulatory sanction itself—a governance/compliance matter involving public reprimand by the listing exchange for disclosure violations. This would materially affect a reasonable investor's assessment of the Company's compliance practices and disclosure reliability.
View raw filing on EDGAR →